Russell L. Delude
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Molecular BiologyGoogle:
"Russell Delude"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kimmel JD, Lacko CS, Delude RL, et al. (2011) Characterizing accelerated capture of deoligomerized TNF within hemoadsorption beads used to treat sepsis. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 98: 47-53 |
| Aneja RK, Sjodin H, Gefter JV, et al. (2011) Small interfering RNA mediated Poly (ADP-ribose) Polymerase-1 inhibition upregulates the heat shock response in a murine fibroblast cell line. Journal of Inflammation (London, England). 8: 3 |
| Gefter JV, Shaufl AL, Fink MP, et al. (2009) Comparison of distinct protein isoforms of the receptor for advanced glycation end-products expressed in murine tissues and cell lines. Cell and Tissue Research. 337: 79-89 |
| Cotoia A, Kameneva MV, Marascalco PJ, et al. (2009) Drag-reducing hyaluronic acid increases survival in profoundly hemorrhaged rats. Shock (Augusta, Ga.). 31: 258-61 |
| Cotoia A, Gefter J, Delude R. (2009) Treatment with p -hydroxyphenylpyruvate in the absence of resuscitation extends survival in rats subjected to lethal blood loss Critical Care. 13: 427 |
| Miki K, Delude R, Killeen M. (2009) Immunostimulated enterocytes activate extracellular arginase I which competes with enterocyte inducible nitric oxide synthase for arginine during inflammation Critical Care. 13: 135 |
| Aneja RK, Tsung A, Sjodin H, et al. (2008) Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. Journal of Leukocyte Biology. 84: 1326-34 |
| Fink MP, Macias CA, Xiao J, et al. (2007) Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants. Critical Care Medicine. 35: S461-7 |
| Fink MP, Macias CA, Xiao J, et al. (2007) Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidants. Biochemical Pharmacology. 74: 801-9 |
| Macias CA, Chiao JW, Xiao J, et al. (2007) Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Annals of Surgery. 245: 305-14 |